6th mRNA Based Therapeutics Summit 2026

 

From major industry‑shaping acquisitions – including Eli Lilly & Orna, BMS & Orbital, AbbVie & Capstan, and BioNTech & CureVac – the mRNA landscape is accelerating rapidly, with assets in in vivo CAR‑T, gene editing, and cancer immunotherapies moving closer to clinical validation and future commercial reality.

Against this backdrop of scientific momentum, the 6th mRNA‑Based Therapeutics Summit returns to Boston this summer as the world’s flagship gathering for the mRNA community. Uniting 350+ global leaders across pharma giants, pioneering biotechs, and regulatory agencies – including Moderna, Pfizer, AstraZeneca, Sanofi, ParcelBio, CaVos Therapeutics, Kernal Biologics, the US FDA, the MHRA and the EMA – the summit showcases exclusive breakthroughs, regulatory perspectives, and cross‑industry collaboration shaping the future of mRNA innovation.

Featuring a revitalized three‑track agenda spanning Discovery, Pre‑Clinical & Clinical Development, and Manufacturing & CMC, plus two brand‑new focus days on AI‑Driven mRNA Design and Next‑Gen Delivery Technologies, the summit stands as the leading platform for scientific exchange, partnership building, and pipeline acceleration.

Join the global community advancing mRNA science and power the next wave of therapies and tools set to transform human health.

More Info

---

---